St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 115   

Articles published

STJ 58.96 +0.68 (1.17%)
price chart
St. Jude Medical Exec on Medtech M&A Trend: Bigger isn't Always Better
Last year, after Medtronic began its foray into the hospital solutions realm with the purchase of remote monitoring firm Cardiocom, St. Jude CEO Daniel Starks said his company would continue to define itself as a �high-tech medical device company ...
Bank Of America Tweaks Numbers For St. Jude Medical, Inc. Lower On F/X, Portico
In a report published Monday, Bank of America analyst Bob Hopkins reiterated a Buy rating and $80.00 price target on St. Jude Medical, Inc. (NYSE: STJ). In the report, Bank of America noted, �Given F/X moves since STJ's Q2 call and STJ's guidance that ...
St. Jude Medical lowers forecast; shares fall
(Reuters) - Heart device maker St. Jude Medical Inc (STJ.N) on Wednesday forecast fourth-quarter revenue below Wall Street estimates, citing soft international sales and unfavorable foreign exchange rates, and its shares fell nearly 4 percent.
St. Jude Medical Reports Third Quarter 2014 Results  MarketWatch
Related articles »  
St. Jude Medical Enters Oversold Territory
But making St. Jude Medical, Inc. an even more interesting and timely stock to look at, is the fact that in trading on Wednesday, shares of STJ entered into oversold territory, changing hands as low as $57.01 per share.
Related articles »  
St. Jude Medical Q3 Profit Beats Estimates; Adjusts Q4 Outlook - Quick Facts
( - St. Jude Medical Inc. ( STJ ) reported third-quarter net earnings attributable to company of $238 million or $0.82 per share, compared to $262 million or $0.90 per share, last year.
Zacks Reiterates Neutral Rating for St. Jude Medical (STJ)
Separately, analysts at Stifel Nicolaus cut their price target on shares of St. Jude Medical from $75.00 to $66.00 in a research note on Thursday.
St. Jude Medical Price Target Lowered to $47.00 at Canaccord Genuity (STJ)  Mideast Time
Related articles »  
St. Jude Medical Price Target Cut to $66.00 (STJ)
St. Jude Medical, Inc. logo St. Jude Medical (NYSE:STJ) had its price target lowered by Stifel Nicolaus from $75.00 to $66.00 in a research report sent to investors on Thursday morning.
St. Jude Medical Inc. (STJ) Dropped To A 10-Month Low After Q3 Report
St. Jude Medical Inc. (STJ: Quote) reported third quarter adjusted EPS of $0.97 Wednesday morning, up from $0.90 in the prior year period.
St. Jude Medical, Inc. (STJ) Issues Q4 Earnings Guidance
St. Jude Medical logo St. Jude Medical, Inc. (NYSE:STJ) issued an update on its fourth quarter earnings guidance on Wednesday morning.
St. Jude Medical Q3 Profit Beats View, But Lowers 2014 Revenue Outlook
( - Medical equipment maker St. Jude Medical Inc. ( STJ ) on Wednesday reported a 9 percent decline in profit for the third quarter from last year, as higher revenues were more than offset by one-time charges.